• Journal of Innovative Optical Health Sciences
  • Vol. 2, Issue 3, 215 (2009)
DAQING PIAO1、*, ZHEN JIANG1, KENNETH E. BARTELS2, G. REED HOLYOAK2, JERRY W. RITCHEY3, GUAN XU1, CHARLES F. BUNTING1, and GENNADY SLOBODOV4
Author Affiliations
  • 1School of Electrical and Computer Engineering Oklahoma State University, Stillwater, OK 74078 USA
  • 2Department of Veterinary Clinical Sciences Oklahoma State University, Stillwater, OK 74078 USA
  • 3Department of Veterinary Pathobiology Oklahoma State University, Stillwater, OK 74078 USA
  • 4Department of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104 USA
  • show less
    DOI: Cite this Article
    DAQING PIAO, ZHEN JIANG, KENNETH E. BARTELS, G. REED HOLYOAK, JERRY W. RITCHEY, GUAN XU, CHARLES F. BUNTING, GENNADY SLOBODOV. IN VIVO TRANS-RECTAL ULTRASOUND-COUPLED NEAR-INFRARED OPTICAL TOMOGRAPHY OF INTACT NORMAL CANINE PROSTATE[J]. Journal of Innovative Optical Health Sciences, 2009, 2(3): 215 Copy Citation Text show less
    References

    [1] Q. Chen, Z. Huang, D. Luck, J. Beckers, P. H. Brun, B. C. Wilson, A. Scherz, Y. Salomon, F. W. Hetzel, “Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers,” Photochem. Photobiol. 76, 438–445 (2002).

    [2] K. K. Wang, L. Lutzke, L. Borkenhagen, W. Westra, M. W. Song, G. Prasad, N. S. Buttar, “Photodynamic therapy for Barrett’s esophagus: Does light still have a role ” Endoscopy 40, 1021–1025 (2008).

    [3] J. B. Wang, L. X. Liu, “Use of photodynamic therapy in malignant lesions of stomach, bile duct, pancreas, colon and rectum,” Hepatogastroenterology 54, 718–724 (2007).

    [4] M. A. D’Hallewin, D. Kochetkov, Y. Viry-Babel, A. Leroux, E. Werkmeister, D. Dumas, S. Gr¨afe, V. Zorin, F. Guillemin, L. Bezdetnaya, “Photodynamic therapy with intratumoral administration of lipidbased mTHPC in a model of breast cancer recurrence,” Lasers Surg. Med. 40, 543–549 (2008).

    [5] B. J. Tromberg, J. Coquoz, O. Fishkin, J. B. Pham, T. Anderson, E. R. Butler, J. Cahn, M. Gross, J. D. Venugopalan, D. Pham, “Non-invasive measurements of breast tissue optical properties using frequency-domain photon migration,” Phil. Trans. R. Soc. Lond. B 352, 661–668 (1997).

    [6] B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, K. D. Paulsen, “Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: Pilot results in the breast,” Radiology 218, 261–266 (2001).

    [7] V. Ntziachristos, B. Chance, “Probing physiology and molecular function using optical imaging: Applications to breast cancer,” Breast Cancer Res. 3, 41–46 (2001).

    [8] R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: A case study with comparison to MRI,” Med. Phys. 32, 1128–1139 (2005).

    [9] M. A. Franceschini, K. T. Moesta, S. Fantini, G. Gaida, E. Gratton, H. Jess, W. W. Mantulin, M. Seeber, P. M. Schlag, M. Kaschke, “Frequencydomain techniques enhance optical mammography: Initial clinical results,” Proc. Nat. Acad. Sci. USA 94, 6468–6473 (1997).

    [10] Q. Zhu, E. B. Cronin, A. A. Currier, H. S. Vine, M. Huang, N. Chen, C. Xu, “Benign versus malignant breast masses: Optical differentiation with USguided optical imaging reconstruction,” Radiology 237, 57–66 (2005).

    [11] H. M. Ross, J. A. Smelstoys, G. J. Davis, A. S. Kapatkin, F. Del Piero, E. Reineke, H. Wang, T. C. Zhu, T. M. Busch, A. G. Yodh, S. M. Hahn, “Photodynamic therapy with motexafin lutetium for rectal cancer: A preclinical model in the dog,” J. Surg. Res. 135, 323–330 (2006).

    [12] A. A. Oraevsky, S. L. Jacques, F. K. Tittel, “Measurement of tissue optical properties by timeresolved detection of laser-induced transient stress,” Appl. Opt. 36, 402–415 (1997).

    [13] Q. Chen, B. C. Wilson, S. D. Shetty, M. S. Patterson, J. C. Cerny, F. W. Hetzel, “Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy,” Radiat. Res. 147, 86–91 (1997).

    [14] L. K. Lee, C.Whitehurst, Q. Chen, M. L. Pantelides, F. W. Hetzel, J. V. Moore, “Interstitial photodynamic therapy in the canine prostate,” Br. J. Urol. 80, 898–902 (1997).

    [15] W. H. Nau, R. J. Roselli, D. F. Milam, “Measurement of thermal effects on the optical properties of prostate tissue at wavelengths of 1,064 and 633 nm,” Lasers Surg. Med. 24, 38–47 (1999).

    [16] L. Lilge, N. Pomerleau-Dalcourt, A. Douplik, S. H. Selman, R. W. Keck, M. Szkudlarek, M. Pestka, J. Jankun, “Transperineal in vivo fluence-rate dosimetry in the canine prostate during SnET2-mediated PDT,” Phys. Med. Biol. 49, 3209–3225 (2004).

    [17] J. Jankun, L. Lilge, A. Douplik, R. W. Keck, M. Pestka, M. Szkudlarek, P. J. Stevens, R. J. Lee, S. H. Selman, “Optical characteristics of the canine prostate at 665nm sensitized with tin etiopurpurin dichloride: Need for real-time monitoring of photodynamic therapy,” J. Urol. 172, 739–743 (2004).

    [18] J. Jankun, R. W. Keck, E. Skrzypczak-Jankun, L. Lilge, S. H. Selman, “Diverse optical characteristic of the prostate and light delivery system: Implications for computer modelling of prostatic photodynamic therapy,” B. J. U. Int. 95, 1237–1244 (2005).

    [19] M. Solonenko, R. Cheung, T. M. Busch, A. Kachur, G. M. Griffin, T. Vulcan, T. C. Zhu, H. W. Wang, S. M. Hahn, A. G. Yodh, “In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys and prostates,” Phys. Med. Biol. 47, 857– 873 (2002).

    [20] T. C. Zhu, S. M. Hahn, A. S. Kapatkin, A. Dimofte, C. E. Rodriguez, T. G. Vulcan, E. Glatstein, R. A. Hsi, “In vivo optical properties of normal canine prostate at 732nm using motexafin lutetiummediated photodynamic therapy,” Photochem. Photobiol. 77, 81–88 (2003).

    [21] G. Xu, D. Piao, C. H. Musgrove, C. F. Bunting, H. Dehghani, “Trans-rectal ultrasound-coupled nearinfrared optical tomography of the prostate Part I: Simulation,” Opt. Exp. 16, 17484–17504 (2008).

    [22] Z. Jiang, D. Piao, G. Xu, J. W. Ritchey, G. R. Holyoak,K. E. Bartels, C. F. Bunting, G. Slobodov, J. S. Krasinski, “Trans-rectal ultrasound-coupled near-infrared optical tomography of the prostate Part II: Experimental demonstration,” Opt. Exp. 16, 17505–17520 (2008).

    [23] J. Boutet, L. Guyon,M. Debourdeau, J. M. Dinten, D. Vray, P. Rizo, “Advances in bi-modal optical and ultrasound detection of prostate cancer diagnosis,” Proc. SPIE 7171, 71710E (2009).

    [24] T. Svensson, S. Andersson-Engels, M. Einarsd′ott′ r, K. Svanberg, “In vivo optical characterization of human prostate tissue using near-infrared timeresolved spectroscopy,” J. Biomed. Opt. 12, 014022 (2007).

    [25] N. Iftimia, H. Jiang, “Quantitative optical image reconstruction of turbid media by use of directcurrent measurements,” Appl. Opt. 39, 5256–5261 (2000).

    [26] H. Xu, MRI-Coupled Broadband Near-Infrared Tomography for Small Animal Brain Studies, Ph.D. Dissertation, Dartmouth College, Hanover, NH, p. 36 (2005).

    [27] F. Bevilacqua, A. J. Berger, A. E. Cerussi, D. Jakubowski, B. J. Tromberg, “Broadband absorption spectroscopy in turbid media by combined frequency-domain and steady-state methods,” Appl. Opt. 39, 6498–6510 (2000).

    DAQING PIAO, ZHEN JIANG, KENNETH E. BARTELS, G. REED HOLYOAK, JERRY W. RITCHEY, GUAN XU, CHARLES F. BUNTING, GENNADY SLOBODOV. IN VIVO TRANS-RECTAL ULTRASOUND-COUPLED NEAR-INFRARED OPTICAL TOMOGRAPHY OF INTACT NORMAL CANINE PROSTATE[J]. Journal of Innovative Optical Health Sciences, 2009, 2(3): 215
    Download Citation